679 related articles for article (PubMed ID: 17880600)
1. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
2. Blood donor screening for parvovirus B19 in Germany and Austria.
Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
Thomas I; Di Giambattista M; Gérard C; Mathys E; Hougardy V; Latour B; Branckaert T; Laub R
Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
6. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
7. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
8. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 transmission by a high-purity factor VIII concentrate.
Wu CG; Mason B; Jong J; Erdman D; McKernan L; Oakley M; Soucie M; Evatt B; Yu MY
Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000
[TBL] [Abstract][Full Text] [Related]
10. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors.
Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Ferreira M; Araújo F
Transfus Apher Sci; 2005 Nov; 33(3):305-9. PubMed ID: 16203176
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
Bonvicini F; Gallinella G; Cricca M; Ambretti S; Delbarba S; Musiani M; Zerbini M
J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory.
Manaresi E; Gallinella G; Zuffi E; Bonvicini F; Zerbini M; Musiani M
J Med Virol; 2002 Jun; 67(2):275-81. PubMed ID: 11992590
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
16. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
Pichl L; Heitmann A; Herzog P; Oster J; Smets H; Schottstedt V
Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
[TBL] [Abstract][Full Text] [Related]
17. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of acute parvovirus B19 infection by immunoglobulin M EIA in combination with a novel antigen EIA.
Corcoran A; Kerr S; Elliott G; Koppelman M; Doyle S
Vox Sang; 2007 Oct; 93(3):216-22. PubMed ID: 17845258
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]